β-Amyloid precursor protein isoforms show correlations with neurones but not with glia of demented subjects

[1]  D. Mann,et al.  Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementias , 1994, Brain Research.

[2]  Paul J. Harrison,et al.  The Effects of Alzheimer's Disease, Other Dementias, and Premortem Course on β‐Amyloid Precursor Protein Messenger RNA in Frontal Cortex , 1994, Journal of neurochemistry.

[3]  M. Pangalos,et al.  Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones , 1993, Brain Research.

[4]  K. Davis,et al.  Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Sims,et al.  Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives , 1993, Journal of neurochemistry.

[6]  D. Neary,et al.  Soluble β-amyloid precursor protein and pyramidal neuron loss , 1993, The Lancet.

[7]  L. Thal,et al.  Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.

[8]  A. Cross,et al.  Protection from dementia. , 1992, Science.

[9]  P. Greengard,et al.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[11]  P. Mcgeer,et al.  Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons , 1992, Brain Research.

[12]  J. Shioi,et al.  Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells , 1992, Journal of neuroscience research.

[13]  R. Martins,et al.  Human Brain βA4 Amyloid Protein Precursor of Alzheimer's Disease: Purification and Partial Characterization , 1992 .

[14]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[15]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[16]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[17]  D. Selkoe,et al.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.

[18]  Richard E. Coggeshall,et al.  A consideration of neural counting methods , 1992, Trends in Neurosciences.

[19]  D. Selkoe,et al.  Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  D. Middlemiss,et al.  Destruction of a sub-population of cortical neurones by suicide transport of volkensin, a lectin from Adenia volkensii , 1991, Journal of Neuroscience Methods.

[21]  J. Trojanowski,et al.  Expression patterns of β‐amyloid precursor protein (β‐APP) in neural and nonneural human tissues from alzheimer's disease and control subjects , 1991 .

[22]  P. Greengard,et al.  Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[24]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[25]  A. Procter,et al.  Rapid autopsy brains for biochemical research: Experiences in establishing a programme , 1990 .

[26]  H. Gundersen,et al.  Unbiased stereological estimation of the number of neurons in the human hippocampus , 1990, The Journal of comparative neurology.

[27]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[28]  T. Powell,et al.  A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[29]  P. Francis,et al.  Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. , 1988, Brain : a journal of neurology.

[30]  M. Esiri,et al.  Topographical distribution of neurochemical changes in Alzheimer's disease , 1988, Journal of the Neurological Sciences.

[31]  D. Neary,et al.  Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease , 1988, Journal of neurochemistry.

[32]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.

[33]  M J Campbell,et al.  Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[35]  D. Neary,et al.  Alzheimer's disease: a correlative study. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[36]  M. A. Spera.  Alzheimerʼs Disease: The Standard Reference , 1985 .

[37]  G K Wilcock,et al.  Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Perry,et al.  The influence of agonal status on some neurochemical activities of postmortem human brain tissue , 1982, Neuroscience Letters.

[39]  H. Braak,et al.  On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease , 2004, Acta Neuropathologica.

[40]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[41]  D. Bowen,et al.  Neurotrophic factor for central cholinergic neurones is present in both normal and Alzheimer brain tissue , 2004, Acta Neuropathologica.

[42]  K. Yoshikawa.  Neurotoxicity of β-amyloid , 1993, Nature.

[43]  Paul J. Harrison,et al.  Terminal coma affects messenger RNA detection in post mortem human temporal cortex. , 1991, Brain research. Molecular brain research.

[44]  J. Trojanowski,et al.  Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. , 1991, Annals of neurology.

[45]  T. Powell,et al.  The Neuroanatomy of Alzheimer's Disease , 1989, Reviews in the neurosciences.

[46]  B. Greenberg,et al.  A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors , 1988 .

[47]  H. Gundersen,et al.  The unbiased estimation of number and sizes of arbitrary particles , 1985 .

[48]  D. Bowen,et al.  Chemical pathology of this organic dementias. II. Quantitative estimation of cellular changes in post-mortem brains. , 1977, Brain : a journal of neurology.

[49]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .